Patent US4578191A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4599228A Expired / Lapsed US ⏱️ 0.0 years remaining

Antimicrobial agent

Assignee: Vipont Pharmaceutical Inc
•
Filing: 1984-01-25
•
Granted: 1986-07-08
•
Expires: 2004-01-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An antimicrobial agent comprising a mineral acid salt of a benzophenanthridine alkaloid in a mixture with a metal salt of an acid.

Inventors

  • 👤 Peter A. Ladanyi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 20:52
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/485; A61K8/00; A61K8/18; A61K8/30; A61K8/49; A61Q; A61Q11/00

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 76 words
A method for treating dental caries in humans comprising applying to the affected area an effective amount of a composition comprising from about 0.1% to 20% by weight of a non-toxic sanguinarine salt, from about 1% to about 60% by weight of zinc chloride, and from about 0.4% to about 3.0% by weight of a non-toxic fluoride salt, in a solvent selected from the group consisting of water, glycerine, propylene glycol, dimethyl sulfoxide, and C1-C6 alcohols.
Claim 2
Independent Claim 76 words
A method for treating dental caries in humans comprising applying to the affected area an effective amount of a composition comprising from about 0.1% to 20% by weight of a non-toxic sanguinarine salt, from about 1% to about 60% by weight of zinc chloride, and from about 0.4% to about 3.0% by weight of a non-toxic fluoride salt, in a solvent selected from the group consisting of water, glycerine, propylene glycol, dimethyl sulfoxide, and C1-C6 alcohols.
Claim 3
Dependent Claim 10 words
The method of claim 1 wherein the solvent is glycerine.
Claim 4
Dependent Claim 22 words
The method of claim 1 wherein the non-toxic fluoride salt is selected from the group consisting of stannous fluoride and sodium fluoride.
Claim 5
Dependent Claim 13 words
The method of claim 3 wherein the non-toxic fluoride salt is stannous fluoride.
Claim 6
Independent Claim 77 words
A method of treating gingivitis in humans comprising topically applying to the affected area an effective amount of a composition comprising from about 0.1% to about 20% by weight of a non-toxic sanguinarine salt, from about 1% to about 60% by weight of zinc chloride, and from about 0.4% to about 3.0% by weight of a non-toxic fluoride salt, in a solvent selected from the group consisting of water, glycerine, propylene glycol, dimethyl sulfoxide, and C1-C6 alcohols.
Claim 7
Independent Claim 77 words
A method of treating gingivitis in humans comprising topically applying to the affected area an effective amount of a composition comprising from about 0.1% to about 20% by weight of a non-toxic sanguinarine salt, from about 1% to about 60% by weight of zinc chloride, and from about 0.4% to about 3.0% by weight of a non-toxic fluoride salt, in a solvent selected from the group consisting of water, glycerine, propylene glycol, dimethyl sulfoxide, and C1-C6 alcohols.
Claim 8
Dependent Claim 10 words
The method of claim 5 wherein the solvent is glycerine.
Claim 9
Dependent Claim 22 words
The method of claim 5 wherein the non-toxic fluoride salt is selected from the group consisting of stannous fluoride and sodium fluoride.
Claim 10
Dependent Claim 13 words
The method of claim 7 wherein the non-toxic fluoride salt is stanous fluoride.
Claim 11
Independent Claim 78 words
A method of treating periodontal disease in humans comprising topically applying to the affected area an effective amount of a composition comprising from about 0.1% to about 20% by weight of a non-toxic sanguinarine salt, from about 1% to about 60% by weight of zinc chloride, and from about 0.4% to about 3.0% by weight of a non-toxic fluoride salt, in a solvent selected from the group consisting of water, glycerine, propylene glycol, dimethyl sulfoxide, and C1-C6 alcohols.
Claim 12
Independent Claim 78 words
A method of treating periodontal disease in humans comprising topically applying to the affected area an effective amount of a composition comprising from about 0.1% to about 20% by weight of a non-toxic sanguinarine salt, from about 1% to about 60% by weight of zinc chloride, and from about 0.4% to about 3.0% by weight of a non-toxic fluoride salt, in a solvent selected from the group consisting of water, glycerine, propylene glycol, dimethyl sulfoxide, and C1-C6 alcohols.
Claim 13
Dependent Claim 10 words
The method of claim 9 wherein the solvent is glycerine.
Claim 14
Dependent Claim 22 words
The method of claim 9 wherein the non-toxic fluoride salt is selected from the group consisting of stannous fluoride and sodium fluoride.
Claim 15
Dependent Claim 13 words
The method of claim 11 wherein the non-toxic fluoride salt is stannous fluoride.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-07-07 1990-01-06 1990-07-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-07-07 1994-01-06 1994-07-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-07-07 1998-01-06 1998-07-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag